FANJ
TMO icon

Financial Architects (New Jersey)’s Thermo Fisher Scientific TMO Stock Holding History

Financial Architects (New Jersey)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$55K – 1459
2019
Q1 		$55K Buy
+200
New +$49.8K 0.01% 582

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Financial Architects (New Jersey)'s TMO Position: Q2 2023 in Review

Financial Architects (New Jersey) increased its Thermo Fisher Scientific (TMO) stake by 9.8% in Q2 2023, buying an estimated $34.5K and bringing the position to 719 shares worth $375K. The position accounts for 0.06% of the portfolio, ranked #236.

Financial Architects (New Jersey) first reported a position in TMO in Q3 2013 and has held it in 19 quarters since. The position peaked at $378K in Q1 2023. 2,388 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Financial Architects (New Jersey) held 719 shares of Thermo Fisher Scientific worth $375K as of Q2 2023.
  • Financial Architects (New Jersey) bought 64 Thermo Fisher Scientific shares in Q2 2023, an estimated $34.5K.
  • Thermo Fisher Scientific made up 0.06% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #236 holding.
  • Financial Architects (New Jersey) first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 19 quarters since.
  • Financial Architects (New Jersey)'s Thermo Fisher Scientific position peaked at $378K in Q1 2023.
  • 2,388 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.